Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 2/2009

01-04-2009 | Original Paper

The Relationship of Sexual Dyad and Personal Network Characteristics and Individual Attributes to Unprotected Sex Among Young Injecting Drug Users

Authors: V. Anna Gyarmathy, Alan Neaigus

Published in: AIDS and Behavior | Issue 2/2009

Login to get access

Abstract

We examine in the heterosexual partnerships (dyads) of IDUs the correlates of engaging in unprotected sex on three levels: individual attributes, social network characteristics, and dyad characteristics. Unprotected sex was significantly less likely to occur in dyads where the participant injected daily or had high safe-sex attitude scores, and in dyads where both members encouraged each other to use condoms. Unprotected sex was significantly more likely to occur in dyads that smoked crack together, shared needles with each other, and where the participant knew that the sex partner had concurrent sex partners. In the sexual dyads of IDUs there is a combined risk of unsafe injecting and unsafe sex. Both injecting and sexual risk, and their combination need to be addressed in interventions that target the sexual partnerships of IDUs. Such interventions should also aim to reduce injected and non-injected crack and other stimulant use associated with high-risk sex.
Literature
Absalon, J., Fuller, C. M., Ompad, D. C., Blaney, S., Koblin, B., Galea, S., & Vlahov, D. (2006). Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City. AIDS and Behavior, 10, 707–715.PubMedCrossRef
Aral, S. O., Hughes, J. P., Stoner, B., Whittington, W., Handsfield, H. H., Anderson, R. M., & Holmes, K. K. (1999). Sexual mixing patterns in the spread of gonococcal and chlamydial infections. American Journal of Public Health, 89, 825–833.PubMedCrossRef
Booth, R. E., Kwiatkowski, C. F., & Chitwood, D. D. (2000). Sex related HIV risk behaviors: Differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug and Alcohol Dependence, 58, 219–226.PubMedCrossRef
Booth, R. E., Watters, J. K., & Chitwood, D. D. (1993). HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. American Journal of Public Health, 83, 1144–1148.PubMedCrossRef
Des Jarlais, D. C., Diaz, T., Perlis, T., Vlahov, D., Maslow, C., Latka, M., Rockwell, R., Edwards, V., Friedman, S. R., Monterroso, E., Williams, I., & Garfein, R. S. (2003). Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. American Journal of Epidemiology, 157, 467–471.PubMedCrossRef
Des Jarlais, D. C., Perlis, T. E., & Settembrino, J. M. (2005). The use of electronic debit cards in longitudinal data collection with geographically mobile drug users. Drug and Alcohol Dependence, 77, 1–5.PubMedCrossRef
Doherty, M. C., Garfein, R. S., Monterroso, E., Latkin, C., & Vlahov, D. (2000). Gender differences in the initiation of injection drug use among young adults. Journal of Urban Health, 77, 396–414.PubMedCrossRef
Dolezal, C., Meyer-Bahlburg, H. F., Liu, X., Ehrhardt, A. A., Exner, T. M., Rabkin, J. G., Gorman, J. M., Marder, K., & Stern, Y. (1999). Longitudinal changes in sexual risk behavior among HIV+ and HIV− male injecting drug users. American Journal of Drug and Alcohol Abuse, 25, 281–303.PubMedCrossRef
El-Bassel, N., Gilbert, L., Wu, E., & Chang, M. (2006). A social network profile and HIV risk among men on methadone: Do social networks matter? Journal of Urban Health, 83, 602–613.PubMedCrossRef
Evans, J. L., Hahn, J. A., Page-Shafer, K., Lum, P. J., Stein, E. S., Davidson, P. J., & Moss, A. R. (2003). Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). Journal of Urban Health, 80, 137–146.PubMedCrossRef
Fennema, J. S., Van Ameijden, E. J., Van Den Hoek, A., & Coutinho, R. A. (1997). Young and recent-onset injecting drug users are at higher risk for HIV. Addiction, 92, 1457–1465.PubMedCrossRef
Frajzyngier, V., Neaigus, A., Gyarmathy, V. A., Miller, M., & Friedman, S. R. (2007). Gender differences in injection risk behaviors at the first injection episode. Drug and Alcohol Dependence, 89, 145–152.PubMedCrossRef
Friedman, S. R., Chapman, T. F., Perlis, T. E., Rockwell, R., Paone, D., Sotheran, J. L., & Des Jarlais, D. C. (1999a). Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991–1996. Journal of Acquired Immune Deficiency Syndromes, 22, 83–91.PubMed
Friedman, S. R., Curtis, R., Neaigus, A., Jose, B., & Des Jarlais, D. C. (1999b). Social networks, drug injectors’ lives, and HIV. New York: Plenum.
Friedman, S. R., Flom, P. L., Kottiri, B. J., Neaigus, A., Sandoval, M., Fuld, J., Curtis, R., Zenilman, J. M., & Des Jarlais, D. C. (2002). Consistent condom use among drug-using youth in a high HIV-risk neighbourhood. AIDS Care, 14, 493–507.PubMedCrossRef
Friedman, S. R., Jose, B., Neaigus, A., Goldstein, M., Curtis, R., Ildefonso, G., Mota, P., & Des Jarlais, D. C. (1994). Consistent condom use in relationships between seropositive injecting drug users and sex partners who do not inject drugs. AIDS, 8, 357–361.PubMedCrossRef
Fuller, C. M., Vlahov, D., Latkin, C. A., Ompad, D. C., Celentano, D. D., & Strathdee, S. A. (2003). Social circumstances of initiation of injection drug use and early shooting gallery attendance: Implications for HIV intervention among adolescent and young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes, 1, 86–93.
Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., & Vlahov, D. (1998). Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, S11–S19.PubMed
Gossop, M., Griffiths, P., Powis, B., & Strang, J. (1992). Severity of dependence and route of administration of heroin, cocaine and amphetamines. British Journal of Addiction, 87, 1527–1536.PubMedCrossRef
Gossop, M., Griffiths, P., Powis, B., & Strang, J. (1993). Severity of heroin dependence and HIV risk. I. Sexual behaviour. AIDS Care, 5, 149–157.PubMedCrossRef
Gyarmathy, V. A., & Neaigus, A. (2006). The effect of personal network exposure on injecting equipment sharing among Hungarian IDUs. Connections, 15, 29–42.
Gyarmathy, V. A., Neaigus, A., & Számadó, S. (2003). HIV risk behavior history of prison inmates in Hungary. AIDS Education and Prevention, 15, 561–569.PubMedCrossRef
Gyarmathy, V. A., Neaigus, A., Ujhelyi, E., Szabó, T., & Rácz, J. (2006). Strong HIV and hepatitis disclosure norms and frequent risk behaviors among Hungarian drug injectors. Drug and Alcohol Dependence, 82, S65–S69.PubMedCrossRef
Heckathorn, D. D. (1997). Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems, 44, 174–199.CrossRef
Klein, H., & Chao, B. S. (1995). Sexual abuse during childhood and adolescence as predictors of HIV-related sexual risk during adulthood among female sexual partners of injection drug users. Violence Against Women, 1, 55–76.PubMedCrossRef
Kral, A. H., Anderson, R., Flynn, N. M., & Bluthenthal, R. N. (2004). Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. Journal of Acquired Immune Deficiency Syndromes, 37, 1307–1312.PubMedCrossRef
Kral, A. H., Lorvick, J., Ciccarone, D., Wenger, L., Gee, L., Martinez, A., & Edlin, B. R. (2005). HIV prevalence and risk behaviors among men who have sex with men and inject drugs in San Francisco. Journal of Urban Health, 82, i43–i50.PubMed
Kral, A. H., Lorvick, J., Gee, L., Bacchetti, P., Rawal, B., Busch, M., & Edlin, B. R. (2003). Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987–1998. American Journal of Epidemiology, 157, 915–922.PubMedCrossRef
Lambert, E., Normand, J., Stall, R., Aral, S., & Vlahov, D. (2005). Introduction: new dynamics of HIV risk among drug-using men who have sex with men. Journal of Urban Health, 82, i1–i8.PubMed
Latka, M. H., Metsch, L. R., Mizuno, Y., Tobin, K., Mackenzie, S., Arnsten, J. H., & Gourevitch, M. N. (2006). Unprotected sex among HIV-positive injection drug-using women and their serodiscordant male partners: role of personal and partnership influences. Journal of Acquired Immune Deficiency Syndromes, 42, 222–228.PubMedCrossRef
Liang, K. Y., & Zeger, S. L. (1986). Longitudinal data analysis using generalized linear models. Biometrika, 73, 13–22.CrossRef
Lorvick, J., Martinez, A., Gee, L., & Kral, A. H. (2006). Sexual and injection risk among women who inject methamphetamine in San Francisco. Journal of Urban Health, 83, 497–505.PubMedCrossRef
Maranda, M. J., Han, C., & Rainone, G. A. (2004). Crack cocaine and sex. Journal of Psychoactive Drugs, 36, 315–322.PubMed
Miller, C. L., Spittal, P. M., LaLiberte, N., Li, K., Tyndall, M. W., O’Shaughnessy, M. V., & Schechter, M. T. (2002). Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. Journal of Acquired Immune Deficiency Syndromes, 30, 335–341.PubMed
MMWR (2006). Methamphetamine use and HIV risk behaviors among heterosexual men-preliminary results from five northern California counties, December 2001–November 2003. Morbidity and Mortality Weekly Report, 55, 273–277.
Morris, M., Podhisita, C., Wawer, M. J., & Handcock, M. S. (1996). Bridge populations in the spread of HIV/AIDS in Thailand. AIDS, 10, 1265–1271.PubMedCrossRef
Neaigus, A., Friedman, S. R., Curtis, R., Des Jarlais, D. C., Furst, R. T., Jose, B., Mota, P., Stepherson, B., Sufian, M., Ward, T., & Wright, J. W. (1994). The relevance of drug injectors’ social networks and risk networks for understanding and preventing HIV infection. Social Science and Medicine, 38, 67–78.PubMedCrossRef
Neaigus, A., Friedman, S. R., Goldstein, M. F., Ildefonso, G., Curtis, R., & Jose B. (1995). Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. NIDA Research Monograph, 151, 20–37.PubMed
Neaigus, A., Friedman, S. R., Jose, B., Goldstein, M. F., Curtis, R., Ildefonso, G., & Des Jarlais, D. C. (1996). High risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 11, 499–509.PubMed
Neaigus, A., Gyarmathy, V. A., Miller, M., Frajzyngier, V., Zhao, M., Friedman, S. R., & Jarlais, D. C. (2007). Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug and Alcohol Dependence, 89, 234–243.PubMedCrossRef
Neaigus, A., Miller, M., Friedman, S. R., & Des Jarlais, D. C. (2001). Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus. Journal of Infectious Diseases, 184, 359–363.PubMedCrossRef
Nelson, K. E., Galai, N., Safaeian, M., Strathdee, S. A., Celentano, D. D., & Vlahov, D. (2002). Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988–1998. American Journal of Epidemiology, 156, 641–653.PubMedCrossRef
Padian, N. S., Shiboski, S. C., Glass, S. O., & Vittinghoff, E. (1997). Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. American Journal of Epidemiology, 146, 350–357.PubMed
Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401.
Rietmeijer, C. A., Wolitski, R. J., Fishbein, M., Corby, N. H., & Cohn, D. L. (1998). Sex hustling, injection drug use, and non-gay identification by men who have sex with men. Associations with high-risk sexual behaviors and condom use. Sexually Transmitted Diseases, 25, 353–360.PubMedCrossRef
Semaan, S., Des Jarlais, D. C., Sogolow, E., Johnson, W. D., Hedges, L. V., Ramirez, G., Flores, S. A., Norman, L., Sweat, M. D., & Needle, R. (2002). A meta-analysis of the effect of HIV prevention interventions on the sex behaviors of drug users in the United States. Journal of Acquired Immune Deficiency Syndromes, 30(Suppl 1), S73–S93.PubMed
Sherman, S. G., & Latkin, C. A. (2001). Intimate relationship characteristics associated with condom use among drug users and their sex partners: a multilevel analysis. Drug and Alcohol Dependence, 64, 97–104.PubMedCrossRef
Sherman, S. G., & Latkin, C. A. (2002). Drug users’ involvement in the drug economy: implications for harm reduction and HIV prevention programs. Journal of Urban Health, 79, 266–277.PubMed
Sifaneck, S., & Neaigus, A. (2001). The ethnographic accessing, sampling and screening of hidden populations: Heroin sniffers in New York City. Addiction Research and Theory, 9, 519–543.CrossRef
Somlai, A. M., Kelly, J. A., McAuliffe, T. L., Ksobiech, K., & Hackl, K. L. (2003). Predictors of HIV sexual risk behaviors in a community sample of injection drug-using men and women. AIDS and Behavior, 7, 383–393.PubMedCrossRef
Strathdee, S. A., & Sherman, S. G. (2003). The role of sexual transmission of HIV infection among injection and non-injection drug users. Journal of Urban Health, 80, iii7–iii14.PubMed
Unger, J. B., Kipke, M. D., De Rosa, C. J., Hyde, J., Ritt-Olson, A., & Montgomery, S. (2006). Needle-sharing among young IV drug users and their social network members: The influence of the injection partner’s characteristics on HIV risk behavior. Addictive Behaviors, 31, 1607–1618.PubMedCrossRef
van Ameijden, E. J.C., & Coutinho, R. A. (1998). Maximum impact of HIV prevention measure targeted at injecting drug users. AIDS, 12, 625–633.PubMedCrossRef
Weeks, M. R., Grier, M., Romero-Daza, N., Puglisi-Vasquez, M. J., & Singer, M. (1998). Streets, drugs, and the economy of sex in the age of AIDS. Women and Health, 27, 205–229.CrossRef
Whiffen, V. E., & Macintosh, H. B. (2005). Mediators of the link between childhood sexual abuse and emotional distress: A critical review. Trauma, Violence and Abuse, 6, 24–39.CrossRef
Metadata
Title
The Relationship of Sexual Dyad and Personal Network Characteristics and Individual Attributes to Unprotected Sex Among Young Injecting Drug Users
Authors
V. Anna Gyarmathy
Alan Neaigus
Publication date
01-04-2009
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2009
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-007-9285-9

Other articles of this Issue 2/2009

AIDS and Behavior 2/2009 Go to the issue

Original Paper

Correlates of Any Condom Use Among Russian Narcology Patients Reporting Recent Unprotected Sex

Original Paper

HIV Illness Representation as a Predictor of Self-care Management and Health Outcomes: A Multi-site, Cross-cultural Study

Erratum

Implementation Challenges to Using Respondent-Driven Sampling Methodology for HIV Biological and Behavioral Surveillance: Field Experiences in International Settings

Original Paper

Alcohol Use, Intimate Partner Violence, Sexual Coercion and HIV among Women Aged 15–24 in Rakai, Uganda

Original Paper

Sub-Saharan African University Students’ Beliefs about Condoms, Condom-use Intention, and Subsequent Condom Use: A Prospective Study

Original Paper

HIV/AIDS Epidemic Features and Trends in Iran, 1986–2006
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits